The prophylactic role of intravenous and long-term oral acyclovir after allogeneic bone marrow transplantation.

Eighty-two patients were randomly allocated to receive intravenous acyclovir 5 mg kg-1 t.d.s. for 23 days followed by oral acyclovir 800 mg 6-hourly for 6 months or matching placebos after allogeneic bone marrow transplantation. Herpes simplex and varicella zoster virus infections were significantly...

Descripción completa

Detalles Bibliográficos
Autores principales: Selby, P. J., Powles, R. L., Easton, D., Perren, T. J., Stolle, K., Jameson, B., Fiddian, A. P., Tryhorn, Y., Stern, H.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1989
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2247066/
https://www.ncbi.nlm.nih.gov/pubmed/2539180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2247066/
https://www.ncbi.nlm.nih.gov/pubmed/2539180

Ejemplares similares